Dr. Mazzone and colleagues report on a cell-free DNA fragmentome assay (DELFIscore) for the classification of lung cancer (1). We have concerns and recommendations. Study participants were enrolled ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation data and review commercial launch timeline BRISBANE, ...

Objectives This study describes the prototype testing and clinical validation of the Fit-Frailty App, a fully guided, interactive mobile health (mHealth) app to assess frailty and sarcopenia. This ...

Hospitals are facing a steady rise in payment disputes over their assignment of a Diagnosis Related Group (DRG). These disputes fall into two general categories: coding-based DRG downgrades and ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication in npj Precision Oncology of the ...

By utilizing a standardized methodology for evaluating novel digital measures, sDHT developers, biostatisticians and clinical researchers will be able to navigate the complex validation landscape more ...

Abstract: Existing research suggests that lower limb exoskeleton robots, when used for rehabilitation training based on the pre-stroke gait trajectories of stroke patients, may be more beneficial for ...

Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study. The study examined ...